Guardant Health GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index. People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay Premium The firm said it will release its colorectal cancer test as an LDT next year and has reorganized its leadership to support future growth in the cancer screening market. Guardant Health Q2 Revenues Grow 39 Percent The firm's oncology testing revenues outpaced other revenue sources, driven by a more than 50 percent increase in clinical test volume. TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology. Jul 19, 2021 Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration Jun 22, 2021 Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product Premium Jun 1, 2021 GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April May 28, 2021 FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen May 28, 2021 Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests May 21, 2021 Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement May 21, 2021 FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC May 7, 2021 Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium May 6, 2021 Guardant Health Q1 Revenues up 17 Percent Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Mar 2, 2021 Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use Feb 26, 2021 Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch Premium Feb 24, 2021 Guardant Health Q4 Revenues Up 25 Percent Feb 19, 2021 New Products Posted to GenomeWeb: Guardant Health, Parse Biosciences, Menarini Silicon Biosystems Feb 5, 2021 Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Dec 18, 2020 People in the News: New Appointments at Fluidigm, Danaher, Guardant Health Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Nov 17, 2020 Guardant Health Prices $1B Senior Notes Offering Load More Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.